home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410l.zip
/
M94A1922.TXT
< prev
next >
Wrap
Text File
|
1994-10-24
|
3KB
|
52 lines
Document 1922
DOCN M94A1922
TI Social and behavioral research in HIV vaccine trials in Rwanda:
identification of priorities.
DT 9412
AU Gasekurume J; Saba J; Souteyrand Y; Ferry B; Ntereye P; N'Sengimana J;
Raynaut C; PAMEVA, Kigali, Rwanda.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):420 (abstract no. PD0290). Unique
Identifier : AIDSLINE ICA10/94370653
AB OBJECTIVES: As Rwanda is one of the four sites selected by WHO for HIV
Vaccine Development, Social and Behavioral Research was identified as an
essential component in preparation of future HIV Vaccine Efficacy
Trials. Major social, behavioral and psychological issues related to
these trials have to be adressed in order to define research priorities.
METHODS: A workshop was held by the National Plan for HIV Vaccine
Development in Kigali and supported by WHO. It involved all social
scientists of the country working on AIDS as well as consultants from
WHO and the National Agency for Research on AIDS in France. The outcome
was reached, in three steps: a brainstorming on the issues to be
addressed in Rwanda, identification of major research directions and
specific research projects ranked according to their priority. RESULTS:
Three research directions including seven research projects that should
be developed in priority were identified: 1) Assessment of level of
information, opinions and attitudes in the population (perception of HIV
infection and AIDS: perception of vaccines and HIV vaccine trials and
analysis of the impact of formal and informal information channels
related to HIV, AIDS, and Vaccines). 2) Volunteering in the trials and
Informed Consent issues (social and behavioral analysis of decision
taking with respect of individual health problems and prevention:
assessment of individual and community acceptability of trial
participation). 3) Sexual behaviour and risk taking (context and factors
associated with sexual behaviour and risk taking: monitoring sexual and
behavioral change in target populations recruited in the epidemiological
studies in preparation for future HIV Vaccine Efficacy Trials).
DISCUSSION AND CONCLUSIONS: Social and behavioral research is one of the
major components of HIV Vaccine Research and field strengthening. Close
collaboration between social scientists, epidemiologists, biologists and
clinicians is essential in preparation for future HIV Vaccine Efficacy
Trials. Such workshop helps scientists in setting up appropriate studies
to better understand attitudes and behaviours of the populations that
might benefit of HIV Vaccine. These studies are planned to start in
Rwanda 1994.
DE Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/ PSYCHOLOGY
*AIDS Vaccines Clinical Trials/*STANDARDS France Human HIV
Infections/*PREVENTION & CONTROL/PSYCHOLOGY Informed Consent Research
Support Risk-Taking Rwanda Sex Behavior World Health Organization
MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).